$FRPT

Cyr William B. sold $6.1M of FRPT

Cyr William B. (Chief Executive Officer) sold 81,922 shares of Freshpet, Inc. (FRPT) at an average of $74.93 ($73.87–$76.01, $6.14M total) across 3 trades over 2026-08-21 to 2026-08-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cyr William B.
Published Aug 25, 2026, 9:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FRPT
Bearish
medium confidence
Mentioned
$FRPT
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FRPTBearishLow
01

Why it matters

The disclosed sale reduces the CEO's ownership by roughly 20%, which could be viewed as a slight negative signal by the market.

02

Market read

Primary insider sale; modest short‑term impact expected, but not a catalyst for major price movement.

03

What to watch

CEO may be diversifying holdings or meeting personal liquidity needs; the company's fundamentals remain unchanged.

Relevance 5/10Novelty 6/10Timing: post-market filing on 2026-08-25

Background

Form 4 filings disclose insider transactions; a CEO sale can be interpreted as a signal but often follows a pre‑arranged plan.

Company-level read

Ticker impact

$FRPTBearishMedium confidence
Context

CEO Cyr William B. sold 81,922 shares for $6.1M via a 10b5-1 plan, reducing his stake to 331,309 shares.

Expected impact

Potential modest downside pressure over the next few days.

Evidence & confidence

The sale size is material for a mid-cap company and disclosed via a Form 4, but it is a routine 10b5-1 transaction.

Market effects

Minimal impact on the pet food sector; insider sales are common and unlikely to shift sector sentiment.

Limited to U.S. investors tracking Freshpet; no broader regional effect.

Low global relevance; only relevant to Freshpet shareholders.

Counterpoint

The sale may be purely procedural under a pre‑arranged 10b5‑1 plan, not reflecting any negative outlook.

Key entities

  • Cyr William B.

    Chief Executive Officer of Freshpet, Inc.

  • Freshpet, Inc.

    Pet food manufacturer listed on NASDAQ under ticker FRPT.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FRPTHighAI 9/10

Freshpet (FRPT) Q2 2026 Earnings Call Transcript

Freshpet (FRPT) reported Q2 2026 results ahead of its guidance range, with its strongest growth rate in over a year and highest adjusted gross margin since Q1 2020. The company raised 2026 sales and adjusted EBITDA guidance. It cited 41% digital order growth to 16.7% of sales, and expects 700 rural lifestyle retail stores by year-end.

$FRPTMed

Freshpet (FRPT) Is Up 12.4% After Raising 2026 Sales Outlook And Margins Improving - Has The Bull Case Changed?

Freshpet (FRPT) shares rose 12.4% after the company reported Q2 sales of $305.59 million and net income of $19.49 million, with improved year-to-date profitability and EPS. Freshpet said a shift toward loyal “MVP” households and higher adjusted gross margin supported lifting 2026 sales growth guidance to 10% to 12%, and it completed an $86.5 million share repurchase.

$FRPTHighAI 9/10

Freshpet CEO says company delivered its strongest growth rate in more than a year, as company announces 2nd quarter results

Freshpet reported Q2 2026 net sales up 15.5% to $305.6 million and gross profit of $128.7 million, 42.1% of sales. Net income rose to $19.5 million. CEO Billy Cyr cited stronger growth and highest adjusted gross margin since Q1 2020. The company updated 2026 guidance to 10% to 12% net sales growth and $210 million to $220 million adjusted EBITDA.

$FRPTHighAI 9/10

Why Are Freshpet (FRPT) Shares Soaring Today

Freshpet (FRPT) shares rose 12.7% after the company reported strong Q2 2026 results. Net sales were $305.6 million, up 15.5% year over year and above the $292.3 million consensus. EPS was $0.39 versus $0.22 expected. Adjusted EBITDA and a full-year adjusted EBITDA forecast midpoint of $215 million also beat estimates.

$FRPTMed

Freshpet Q2 Earnings Call Highlights

Freshpet (FRPT) said its low-end sales outlook assumes stable macro conditions, while hitting the high end would require stronger advertising, omnichannel gains, more distribution, faster category growth, and a return of trade-up. Q2 adjusted gross margin rose 170 bps to 48.6%. 2026 adjusted gross margin improvement guidance increased to 100 to 150 bps at the midpoint. Operating cash flow rose 31% to $44.4M; free cash flow was $14.7M.

$FRPTMedAI 8/10

Freshpet’s (NASDAQ:FRPT) Q2 CY2026: Strong Sales, Stock Soars

Freshpet (NASDAQ:FRPT) reported Q2 CY2026 results. Revenue rose 15.5% year on year to $305.6 million, exceeding Wall Street estimates by 4.5%, and GAAP profit was $0.39 per share, 73.6% above consensus. The article also cites analyst expectations for 7.1% revenue growth over the next 12 months and notes the stock rose 7.6% to $67.10 after the report.